POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

Saved in:
Bibliographic Details
Published in:Kidney international reports 2021-04, Vol.6 (4), p.S361-S362
Main Authors: Chertow, G.M., Vart, P., Jongs, N., Toto, R.D., Gorriz, J.L., Hou, F.F., McMurray, J.J.V., Correa-Rotter, R., Rossing, P., Sjöström, C.D., Stefánsson, B.V., Langkilde, A.M., Wheeler, D.C., Lambers Heerspink, H.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2468-0249
2468-0249
DOI:10.1016/j.ekir.2021.03.869